Birdwatch Note
2023-04-14 22:44:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
IVM is not an antimalarial drug https://www.cochrane.org/CD013117/INFECTN_malaria-control-using-ivermectin
Written by 8E2BA73E12AF4C501F07CFC148A27544B50BF2C5005A428C1CF40AA738BFE37A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1646939779102023689
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1647008046474838021
- noteId - 1647008046474838021
- participantId -
- noteAuthorParticipantId - 8E2BA73E12AF4C501F07CFC148A27544B50BF2C5005A428C1CF40AA738BFE37A Participant Details
- createdAtMillis - 1681512292868
- tweetId - 1646939779102023689
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- IVM is not an antimalarial drug https://www.cochrane.org/CD013117/INFECTN_malaria-control-using-ivermectin
Note Ratings
| rated at | rated by | |
| 2023-04-14 19:00:46 -0500 | Rating Details | |
| 2023-04-14 18:47:20 -0500 | Rating Details | |
| 2023-04-15 02:11:10 -0500 | Rating Details | |
| 2023-04-14 20:42:39 -0500 | Rating Details | |
| 2023-04-14 23:34:53 -0500 | Rating Details | |
| 2023-04-14 18:54:43 -0500 | Rating Details | |
| 2023-04-14 19:12:40 -0500 | Rating Details | |
| 2023-04-15 01:48:48 -0500 | Rating Details | |
| 2023-04-14 19:36:58 -0500 | Rating Details | |
| 2023-04-15 01:11:33 -0500 | Rating Details | |
| 2023-04-15 01:47:57 -0500 | Rating Details | |
| 2023-04-14 17:50:16 -0500 | Rating Details | |
| 2023-04-15 00:16:30 -0500 | Rating Details | |
| 2023-04-15 04:54:59 -0500 | Rating Details | |
| 2023-04-14 19:02:12 -0500 | Rating Details | |
| 2023-04-16 11:32:43 -0500 | Rating Details | |
| 2023-04-14 17:54:56 -0500 | Rating Details | |
| 2023-04-15 09:26:58 -0500 | Rating Details | |
| 2023-04-15 01:13:30 -0500 | Rating Details | |
| 2023-04-14 19:31:47 -0500 | Rating Details | |
| 2023-04-15 02:29:13 -0500 | Rating Details | |
| 2023-04-15 00:45:21 -0500 | Rating Details | |
| 2023-04-15 03:38:58 -0500 | Rating Details | |
| 2023-04-15 00:29:26 -0500 | Rating Details | |
| 2023-04-15 00:49:08 -0500 | Rating Details | |
| 2023-04-16 01:03:13 -0500 | Rating Details | |
| 2023-04-15 00:03:43 -0500 | Rating Details | |
| 2023-04-15 01:08:57 -0500 | Rating Details | |
| 2023-04-15 02:31:31 -0500 | Rating Details | |
| 2023-04-14 19:00:46 -0500 | Rating Details | |
| 2023-04-14 18:47:20 -0500 | Rating Details | |
| 2023-04-15 02:11:10 -0500 | Rating Details | |
| 2023-04-14 20:42:39 -0500 | Rating Details | |
| 2023-04-14 23:34:53 -0500 | Rating Details | |
| 2023-04-14 18:54:43 -0500 | Rating Details | |
| 2023-04-14 19:12:40 -0500 | Rating Details | |
| 2023-04-15 01:48:48 -0500 | Rating Details | |
| 2023-04-14 19:36:58 -0500 | Rating Details | |
| 2023-04-15 01:11:33 -0500 | Rating Details | |
| 2023-04-15 01:47:57 -0500 | Rating Details | |
| 2023-04-14 17:50:16 -0500 | Rating Details | |
| 2023-04-15 00:16:30 -0500 | Rating Details | |
| 2023-04-15 04:54:59 -0500 | Rating Details | |
| 2023-04-14 19:02:12 -0500 | Rating Details | |
| 2023-04-16 11:32:43 -0500 | Rating Details | |
| 2023-04-14 17:54:56 -0500 | Rating Details | |
| 2023-04-15 09:26:58 -0500 | Rating Details | |
| 2023-04-15 01:13:30 -0500 | Rating Details | |
| 2023-04-14 19:31:47 -0500 | Rating Details | |
| 2023-04-15 02:29:13 -0500 | Rating Details | |
| 2023-04-15 00:45:21 -0500 | Rating Details | |
| 2023-04-15 03:38:58 -0500 | Rating Details | |
| 2023-04-15 00:29:26 -0500 | Rating Details | |
| 2023-04-15 00:49:08 -0500 | Rating Details | |
| 2023-04-16 01:03:13 -0500 | Rating Details | |
| 2023-04-15 00:03:43 -0500 | Rating Details | |
| 2023-04-15 01:08:57 -0500 | Rating Details | |
| 2023-04-15 02:31:31 -0500 | Rating Details |